DK2086940T3 - Fumaratsalt af (alfa- s, beta-r)-6-brom-alfa-[2-(dimethylamino)-ethyl]-2-methoxy-alfa-1-naphthalenyl-beta-phenyl-3-quinolinethanol - Google Patents
Fumaratsalt af (alfa- s, beta-r)-6-brom-alfa-[2-(dimethylamino)-ethyl]-2-methoxy-alfa-1-naphthalenyl-beta-phenyl-3-quinolinethanolInfo
- Publication number
- DK2086940T3 DK2086940T3 DK07847697.5T DK07847697T DK2086940T3 DK 2086940 T3 DK2086940 T3 DK 2086940T3 DK 07847697 T DK07847697 T DK 07847697T DK 2086940 T3 DK2086940 T3 DK 2086940T3
- Authority
- DK
- Denmark
- Prior art keywords
- alfa
- beta
- quinolinethanol
- brom
- naphthalenyl
- Prior art date
Links
- MAUMSNABMVEOGP-UHFFFAOYSA-N (methyl-$l^{2}-azanyl)methane Chemical class C[N]C MAUMSNABMVEOGP-UHFFFAOYSA-N 0.000 title 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06125443 | 2006-12-05 | ||
PCT/EP2007/063186 WO2008068231A1 (en) | 2006-12-05 | 2007-12-03 | Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2086940T3 true DK2086940T3 (da) | 2012-08-20 |
Family
ID=37983588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07847697.5T DK2086940T3 (da) | 2006-12-05 | 2007-12-03 | Fumaratsalt af (alfa- s, beta-r)-6-brom-alfa-[2-(dimethylamino)-ethyl]-2-methoxy-alfa-1-naphthalenyl-beta-phenyl-3-quinolinethanol |
Country Status (34)
Country | Link |
---|---|
US (1) | US8546428B2 (da) |
EP (1) | EP2086940B1 (da) |
JP (2) | JP2010511663A (da) |
KR (1) | KR101514700B1 (da) |
CN (2) | CN105012303A (da) |
AP (1) | AP2498A (da) |
AR (1) | AR064149A1 (da) |
AU (1) | AU2007328945B2 (da) |
BR (1) | BRPI0719693A2 (da) |
CA (1) | CA2668512C (da) |
CL (1) | CL2007003472A1 (da) |
CY (1) | CY1113594T1 (da) |
DK (1) | DK2086940T3 (da) |
EA (1) | EA017091B9 (da) |
ES (1) | ES2387923T3 (da) |
HK (1) | HK1214513A1 (da) |
HR (1) | HRP20120639T1 (da) |
IL (1) | IL199077A (da) |
JO (1) | JO2973B1 (da) |
ME (1) | ME01456B (da) |
MX (1) | MX2009005909A (da) |
MY (1) | MY148844A (da) |
NO (1) | NO342773B1 (da) |
NZ (1) | NZ576485A (da) |
PE (1) | PE20081350A1 (da) |
PL (1) | PL2086940T3 (da) |
PT (1) | PT2086940E (da) |
RS (1) | RS52408B (da) |
SI (1) | SI2086940T1 (da) |
TW (1) | TWI417098B (da) |
UA (1) | UA97813C2 (da) |
UY (1) | UY30762A1 (da) |
WO (1) | WO2008068231A1 (da) |
ZA (1) | ZA200903907B (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120010216A1 (en) * | 2010-07-06 | 2012-01-12 | Brown Arthur M | Pharmaceutical compositions containing vanoxerine |
CZ2014708A3 (cs) * | 2014-10-16 | 2016-04-27 | Zentiva, K.S. | Soli Bedaquilinu |
IL253626B1 (en) * | 2015-01-27 | 2024-04-01 | Janssen Pharmaceutica Nv | dispersible preparations |
CN106279017A (zh) * | 2015-05-21 | 2017-01-04 | 重庆圣华曦药业股份有限公司 | 贝达喹啉晶型、组合物及其制备方法 |
CZ2015391A3 (cs) * | 2015-06-09 | 2016-12-21 | Zentiva, K.S. | Sůl bedaquilinu s kyselinou citronovou |
US10196360B2 (en) | 2015-10-20 | 2019-02-05 | Zhejiang Hisun Pharmaceutical Co., Ltd. | Crystal forms of bedaquiline fumarate and preparation methods therefor |
AU2017298187B2 (en) * | 2016-07-20 | 2019-11-14 | Novartis Ag | Aminopyridine derivatives and their use as selective ALK-2 inhibitors |
CN106316943A (zh) * | 2016-07-27 | 2017-01-11 | 重庆华邦制药有限公司 | 富马酸贝达喹啉晶型化合物的精制方法 |
JP2022516671A (ja) | 2019-01-09 | 2022-03-01 | ヤンセン ファーマシューティカ エヌ.ベー. | 非結核性抗酸菌症の処置における組合せ |
WO2020161743A1 (en) * | 2019-02-08 | 2020-08-13 | Mylan Laboratories Limited | Process for the preparation of bedaquiline fumarate |
KR102303635B1 (ko) * | 2020-07-01 | 2021-09-17 | 동아에스티 주식회사 | (1r,2s)-1-(6-브로모-2-메톡시퀴놀린-3-일)-4-디메틸아미노-2-(1-나프틸)-1-페닐-부탄-2-올 및 이의 약제학적으로 허용 가능한 염의 제조방법 |
CN111888477B (zh) * | 2020-09-15 | 2023-03-07 | 北京福元医药股份有限公司 | 一种贝达喹啉药物制剂 |
JP2023549605A (ja) | 2020-11-12 | 2023-11-28 | ヤンセン ファーマシューティカ エヌ.ベー. | 非結核性マイコバクテリア疾患の治療におけるベダキリン、エタンブトール、及びマクロライドの組合せ |
US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
WO2023150747A1 (en) | 2022-02-07 | 2023-08-10 | Insmed Incorporated | Dry powder compositions of bedaquiline and salts and methods of use thereof |
WO2023232838A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Pharmaceutica Nv | Bedaquiline for use in the treatment of leprosy |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3237575A1 (de) * | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale mopidamolformen |
GB8824392D0 (en) * | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
TW355683B (en) * | 1994-02-17 | 1999-04-11 | Janssen Pharmaceutica Nv | Composition containing micronized nebivolol |
WO1998018326A1 (en) * | 1996-10-28 | 1998-05-07 | Department Of The Army, U.S. Government | Compounds, compositions and methods for treating antibiotic-resistant infections |
CA2219377A1 (en) * | 1996-10-30 | 1998-04-30 | Eli Lilly And Company | Improvements in or relating to the prophylaxis of breast cancer |
US6819464B2 (en) * | 2002-06-19 | 2004-11-16 | Seiko Epson Corporation | Optical modulator, optical device and projector |
EP1527050B1 (en) * | 2002-07-25 | 2010-04-07 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
WO2004050068A1 (en) * | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
JO2524B1 (en) * | 2004-05-28 | 2010-03-17 | جانسن فارمسيتكا ان في | Use of substituted quinoline derivatives to treat drug-resistant microbial diseases |
WO2006024667A1 (en) * | 2004-09-02 | 2006-03-09 | Janssen Pharmaceutica N.V. | Furamate of 4-( (4-( (4- (2-cyanoethenyl) -2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile |
EA009779B1 (ru) * | 2004-12-24 | 2008-04-28 | Янссен Фармацевтика Н.В. | Лечение латентного туберкулёза |
-
2007
- 2007-03-12 UA UAA200904218A patent/UA97813C2/uk unknown
- 2007-12-02 JO JO2007511A patent/JO2973B1/en active
- 2007-12-03 PL PL07847697T patent/PL2086940T3/pl unknown
- 2007-12-03 ME MEP-2012-95A patent/ME01456B/me unknown
- 2007-12-03 CN CN201510368829.1A patent/CN105012303A/zh active Pending
- 2007-12-03 SI SI200730984T patent/SI2086940T1/sl unknown
- 2007-12-03 CN CNA2007800448088A patent/CN101547904A/zh active Pending
- 2007-12-03 MX MX2009005909A patent/MX2009005909A/es active IP Right Grant
- 2007-12-03 PT PT07847697T patent/PT2086940E/pt unknown
- 2007-12-03 ES ES07847697T patent/ES2387923T3/es active Active
- 2007-12-03 US US12/515,986 patent/US8546428B2/en active Active
- 2007-12-03 DK DK07847697.5T patent/DK2086940T3/da active
- 2007-12-03 BR BRPI0719693-8A2A patent/BRPI0719693A2/pt not_active Application Discontinuation
- 2007-12-03 AU AU2007328945A patent/AU2007328945B2/en active Active
- 2007-12-03 KR KR1020097011043A patent/KR101514700B1/ko active IP Right Grant
- 2007-12-03 RS RS20120336A patent/RS52408B/en unknown
- 2007-12-03 AP AP2009004870A patent/AP2498A/xx active
- 2007-12-03 JP JP2009539724A patent/JP2010511663A/ja active Pending
- 2007-12-03 CL CL200703472A patent/CL2007003472A1/es unknown
- 2007-12-03 EA EA200970532A patent/EA017091B9/ru active Protection Beyond IP Right Term
- 2007-12-03 EP EP07847697A patent/EP2086940B1/en active Active
- 2007-12-03 WO PCT/EP2007/063186 patent/WO2008068231A1/en active Application Filing
- 2007-12-03 MY MYPI20092284A patent/MY148844A/en unknown
- 2007-12-03 CA CA2668512A patent/CA2668512C/en active Active
- 2007-12-03 NZ NZ576485A patent/NZ576485A/en unknown
- 2007-12-04 TW TW096146000A patent/TWI417098B/zh active
- 2007-12-05 AR ARP070105442A patent/AR064149A1/es not_active Application Discontinuation
- 2007-12-05 PE PE2007001719A patent/PE20081350A1/es active IP Right Grant
- 2007-12-05 UY UY30762A patent/UY30762A1/es active IP Right Grant
-
2009
- 2009-06-02 IL IL199077A patent/IL199077A/en active IP Right Grant
- 2009-06-04 ZA ZA2009/03907A patent/ZA200903907B/en unknown
- 2009-07-06 NO NO20092535A patent/NO342773B1/no unknown
-
2012
- 2012-08-06 HR HRP20120639TT patent/HRP20120639T1/hr unknown
- 2012-08-13 CY CY20121100734T patent/CY1113594T1/el unknown
-
2014
- 2014-09-19 JP JP2014191134A patent/JP5894239B2/ja active Active
-
2016
- 2016-03-04 HK HK16102481.4A patent/HK1214513A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2086940T3 (da) | Fumaratsalt af (alfa- s, beta-r)-6-brom-alfa-[2-(dimethylamino)-ethyl]-2-methoxy-alfa-1-naphthalenyl-beta-phenyl-3-quinolinethanol | |
DK2101570T3 (da) | Tannatsalt af rasagilin | |
BRPI0722082A2 (pt) | Ligantes para imagiologia da inervação cardíaca | |
DE502008000295D1 (de) | Nockenwelle | |
DE112007002915A5 (de) | Verstelleinrichtung | |
DE502007002976D1 (de) | Nockenwelle | |
FR2908035B1 (fr) | Implant interepineux | |
BRPI0814314A2 (pt) | Microbiocidas | |
ATE449068T1 (de) | Neue mikrobiozide | |
DE502007001122D1 (de) | Humeruskomponente | |
DK2114147T3 (da) | Reduktion af bivirkninger af tramadol | |
SE0602723L (sv) | Belagt skär | |
DE112007000221A5 (de) | Abseilvorrichtung | |
BRPI0813781A2 (pt) | microbiocidas | |
ATE523493T1 (de) | 2-(1-oxo-1h-isochinolin-2-yl) acetamid-derivate | |
DK2054363T3 (da) | Asymmetrisk hydrogenering af 1,1,1-trifluoracetone | |
DE502006005208D1 (de) | Kochgefäss | |
DE602007002163D1 (de) | Weichspülmittel | |
DE502006007220D1 (de) | Nockenwelle | |
DK2089708T3 (da) | Forudsigelige kræft-immunterapi parametre | |
DK2046745T3 (da) | Fremgangsmåde til fremstilling af amorft lercanidipin-hydrochlorid | |
DE602007011413D1 (de) | Phasenregelkreiselement | |
ITVI20060074A1 (it) | Struttura di ancoraggio,particolarmente per radiatori | |
FI20065528A0 (fi) | Moniresonanssiantenni | |
ITMI20060760A1 (it) | Procedimento per il trattamento di tessuti |